Figures & data
TABLE 1 The effect of formulations on Cadrbamzepine microspheres characteristics
FIG. 1 INfrared spectra of CBZ, PLGA, and CBZ loaded to PLGA, where: A = Pure CBZ, B = RG506, C = RG 858, D = CBZ:RG 506 (1:3) microspheres and E = CBZ:RG 506 (1:3) microspheres.
![FIG. 1 INfrared spectra of CBZ, PLGA, and CBZ loaded to PLGA, where: A = Pure CBZ, B = RG506, C = RG 858, D = CBZ:RG 506 (1:3) microspheres and E = CBZ:RG 506 (1:3) microspheres.](/cms/asset/473cf528-0214-4b7e-93ef-195af57f858f/idrd_a_130882_uf0001_b.gif)
FIG. 2 Differential scanning calorimetry of CBZ, PLGA microspheres where: A = Pure CBZ, B = RG506, C = R208, D = RG858, E = CBZ:(RG858 + 208) 1:3, and F = CBZ:(RG858 + 506) 1:3.
![FIG. 2 Differential scanning calorimetry of CBZ, PLGA microspheres where: A = Pure CBZ, B = RG506, C = R208, D = RG858, E = CBZ:(RG858 + 208) 1:3, and F = CBZ:(RG858 + 506) 1:3.](/cms/asset/8a5c3a77-25b4-4893-a335-8f6abbec5e6e/idrd_a_130882_uf0002_b.gif)
FIG. 3 The electron scanning micrographs of CBZ-PLGA microspheres, in the presence “A” or absence “B” of pluronic (0.5%) in the formulation process, respectively.
![FIG. 3 The electron scanning micrographs of CBZ-PLGA microspheres, in the presence “A” or absence “B” of pluronic (0.5%) in the formulation process, respectively.](/cms/asset/9c031e57-af45-4ca6-b5e9-971960936133/idrd_a_130882_uf0003_b.gif)
FIG. 4 The in vitro release of CBZ loaded to microspheres prepared with polymers with different Lacide and glycolide content.
![FIG. 4 The in vitro release of CBZ loaded to microspheres prepared with polymers with different Lacide and glycolide content.](/cms/asset/e6ba9ab1-bc89-4831-ad1b-eb19c036b22e/idrd_a_130882_uf0004_b.gif)
FIG. 5 The effect of 0.5% Pluronic F-68 (P) on the in vitro release of CBZ from CBZ-PLGA (RG 858) prepared in different ratios.
![FIG. 5 The effect of 0.5% Pluronic F-68 (P) on the in vitro release of CBZ from CBZ-PLGA (RG 858) prepared in different ratios.](/cms/asset/b370df90-8c74-4628-bb81-764b69fee5cf/idrd_a_130882_uf0005_b.gif)
FIG. 6 The in vitro release profile of CBZ from mixtures of RG858 + R208 PLGA-PLA-based microspheres in the presence of 0.5% Pluronic F-68.
![FIG. 6 The in vitro release profile of CBZ from mixtures of RG858 + R208 PLGA-PLA-based microspheres in the presence of 0.5% Pluronic F-68.](/cms/asset/e78b648b-bbb7-4881-9456-98c19dfc7e99/idrd_a_130882_uf0006_b.gif)
FIG. 7 The in vitro release profile of CBZ from mixtures of RG506 + R208 PLGA-PLA = based microspheres in the presence of 0.5% Pluronic F-68.
![FIG. 7 The in vitro release profile of CBZ from mixtures of RG506 + R208 PLGA-PLA = based microspheres in the presence of 0.5% Pluronic F-68.](/cms/asset/ac064199-63c5-495e-839b-50e7ef9b708f/idrd_a_130882_uf0007_b.gif)
TABLE 2 Mean release kinetic parameters of carbamazepine from different microsphere formulations